Skip to main content
padlock icon - secure page this page is secure

Bee Venom: Its Potential Use in Alternative Medicine

Buy Article:

$68.00 + tax (Refund Policy)

In recent times, bee venom (BV) from honey bee (Apis mellifera L.) has become the focus of interest as a form of alternative and preventive medicine for the treatment of a number of clinical cases such as arthritis, rheumatism, pain, cancer and a vast range of other conditions. BV contains several biochemically and pharmacologically active substances. Some of these compounds are well studied and their mechanisms of action established, despite the fact that few are undergoing clinical trials. Scientists are now performing intensive research work especially human clinical trials to improve the potential use of BV and its chemical constituents as the next drugs generation in the treatment of chronic disorders. Nevertheless, the dual effect of some bee venom components is also important in the design of future therapeutic goals. This paper gives recent evidences on the chemical and biological properties of the major components of bee venom, their underlying molecular action mechanism, and reasons of its consideration as a promising alternative medicine.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Alternative medicine; bee venom; biological properties; chronic disorders; clinical trials; molecular mechanism

Document Type: Research Article

Publication date: April 1, 2015

More about this publication?
  • Anti-Infective Agents publishes original research, expert reviews, drug clinical trial studies and guest edited issues on all the latest and outstanding developments on the medicinal chemistry, biology, pharmacology and use of anti-infective and anti-parasitic agents. The scope of the journal covers all pre-clinical and clinical research on antimicrobials, antibacterials, antiviral, antifungal, and antiparasitic agents. Anti-Infective Agents is an essential journal for all infectious disease researchers in industry, academia and the health services.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more